Top compounds associated with response to TXNDC17


Feature Type Standardized
Nominal ANOVA
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.089 0.02
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.091 0.02
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
mRNA Nilotinib CCLE pan-cancer AAC -0.12 0.02
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.08 0.02
mRNA lovastatin CTRPv2 pan-cancer AAC 0.089 0.02
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA PI-103 GDSC1000 pan-cancer AAC -0.073 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.02
Download CSV